Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. - Wikidata - awgldk - TriplyDB

Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions.

Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions.

http://www.wikidata.org/entity/Q40578581

about

Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine Nanopharmaceuticals (part 2): products in the pipeline Amine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungs Radioactive Nanomaterials for Multimodality Imaging Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth CORR Insights(®): survival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the knee Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe.Prophylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burn.Ligand-targeted theranostic nanomedicines against cancer Development of a clickable bimodal fluorescent/PET probe for in vivo imaging.A Review of Clinical Translation of Inorganic Nanoparticles.Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle Radio-nanomaterials for biomedical applications: state of the art Nonporous Silica Nanoparticles for Nanomedicine Application.Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.Near-Infrared Intraoperative Chemiluminescence Imaging.uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.Dye-doped silica nanoparticles as luminescent organized systems for nanomedicine.Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents.Advances and perspectives in nanoprobes for noninvasive lymph node mapping.Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challenges.Silica-based mesoporous nanobiomaterials as promoter of bone regeneration process.Investigating the susceptibility of mice to a bacterial challenge after intravenous exposure to durable nanoparticles.Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization.Clinical advances of nanocarrier-based cancer therapy and diagnostics.Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.Simple and Sensitive Point-of-Care Bioassay System Based on Hierarchically Structured Enzyme-Mimetic Nanoparticles.Multifunctional nanoparticles as a tissue adhesive and an injectable marker for image-guided procedures.Synthesis, radiosynthesis and in vitro evaluation of 18F-Bodipy-C16/triglyceride as a dual modal imaging agent for brown adipose tissue.Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies.Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations.Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.Are they in or out? The elusive interaction between Qtracker ® 800 vascular labels and brain endothelial cells.Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells.Towards clinically translatable in vivo nanodiagnostics.

P2860

Q26770108-282B5BC0-CCFB-4C84-9150-317F80445A2C Q26824153-5C23A96B-8960-4AB7-B847-BF4FE6EAA589 Q28397622-4EC7BCF6-D409-45EB-8A70-A5E359B0310E Q28833646-09E4A3E7-9CEA-44F0-9235-D2DF0328FE87 Q30543887-91F71491-C387-44E2-8CB4-750F866FBEF1 Q30828545-76444D9E-01F5-4669-BDE0-4ED105A75D33 Q35267836-0F3DF8FD-A35F-437D-BA71-51C52929F0C6 Q35590083-3D6F2CC9-BC3C-4A4C-8344-10A09AA6FD22 Q35884453-447AD491-1AD9-4D57-B448-AC60E8423687 Q35895637-E70C6615-CE21-47F7-B38B-2F1BEA1D4602 Q35967818-5E1DBC42-C44B-446C-955E-6906CBF36211 Q35967907-A05D347E-8856-460E-BDE6-0CA93ACF243E Q36994123-3F28E84C-01EF-4DD6-AC2A-9DA31AECDF37 Q37131224-E1396608-8008-406F-B583-8FAA49724C35 Q37131939-3B643EC7-8008-4DD9-BDE4-51729509341C Q37133577-84ABBC4D-7A21-459B-83E7-F1C40313A0D8 Q37134529-0B8C0BAB-D51E-4F94-B557-FD6D0993E5A2 Q37333843-82EF4095-AAE5-4490-A42A-5C9C94EB99F9 Q37435242-94D39D33-2A98-4B36-91B9-953FE3CCC016 Q38197082-1222F4D8-4093-4E7B-BCAB-11736F443E7D Q38269215-BDF24170-9DCF-4FAC-A0B1-AE6ED5DC26D8 Q38418319-37EE2193-4704-4880-9F98-67E103980517 Q38444608-1538F087-994D-4448-9CB5-882DE395E74A Q38502952-42EEF61D-0E2E-4197-9C2D-0BA726557FE2 Q38626361-A4E37CD0-2F9E-47A2-98D8-DA427BB0BFCD Q38828281-4EE92AE6-BCEC-4254-AB61-B6854299A2A2 Q38848965-2E9F743F-FCEE-46E0-BF69-EE9B0FFB3E05 Q39342232-31D057E5-35B3-47DD-891E-A3310A2F3C3A Q40271698-1DD0509D-C1FA-4A04-A525-C47C757389E6 Q41109536-211AE745-7C6B-4347-98BC-9C5761090185 Q41444867-A36464C6-028E-40C2-90D9-38215FB4AD23 Q41448000-A4F84C07-16B1-4881-A376-07ACEBAF0B8B Q47142621-D05563E0-4290-4487-B91C-4CD817C0F670 Q47147487-B8D81208-8FFF-44D5-BB15-FDCF3E14E96A Q47962563-BD8505E1-E817-4B01-8363-BFDB53EE20E3 Q48661023-97184897-449A-4F27-9F20-F4931A799BEF Q50422486-9FBC2ADF-6CC6-4C4C-9123-70659B208E98 Q52718880-B6140CAC-DB67-4866-81D4-99266912D255 Q52725211-D7F69D64-9090-46FA-8D01-BD197121DA0E Q54985361-4F39078C-7B3C-4C84-9054-B0D2A705A491

P2860

Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions.

http://www.wikidata.org/entity/Q40578581

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Clinically-translated silica n ...... ded surgery and interventions.

@en

type

label

Clinically-translated silica n ...... ded surgery and interventions.

@en

prefLabel

Clinically-translated silica n ...... ded surgery and interventions.

@en

P1433

Q40578581-BA3D122A-7BD4-4E8F-A64B-AE19B0BB7D26

P1476

Q40578581-862B9F56-9409-450F-9050-A4D162FC477C

P2093

Q40578581-0ACBFB6E-634F-4A39-9CEC-9450B7C04F5D

Q40578581-1D52BEC0-5120-4B46-8CC5-874FBD763C16

Q40578581-393E4AAF-455B-49E0-BFC4-8EA329F4F3B3

Q40578581-4E16CB4F-1F88-456E-9FF8-F7C4655DA269

Q40578581-557DBF05-BA2B-43D6-8D05-3EE48F0704AE

Q40578581-8093B33E-8F9B-4E39-80C3-5E46CFE0A974

Q40578581-C69225C3-9300-4524-824E-104FEB556E1A

Q40578581-DBECAFDD-EB86-44D4-9ED0-BA7CD881F591

Q40578581-F67BD91F-AD70-4EBA-A5F7-C5DF6F5D5386

P2860

Q40578581-0214B835-47E7-4A2C-93CD-87FD96D569E6

Q40578581-04E150A3-1064-4B78-BAA3-38BD6A39E0E0

Q40578581-0B37E3B5-A760-4A83-8D32-B7167814BA98

Q40578581-180B3CD1-9B6A-40C3-8F45-6D8CBDA2CA25

Q40578581-1B4134A7-EC9D-45BE-9A03-64A42660DACE

Q40578581-26CE2B5B-754E-43C8-A34E-B8DABAA1CA63

Q40578581-279A7888-4575-4078-AEAB-19DD6DE10E0D

Q40578581-2A656C16-EF00-436D-8B38-144A1E765D0F

Q40578581-2C6E1451-0F6E-4D8A-A9D7-4B64CE74AA41

Q40578581-30130271-0687-474C-8F79-574757B1CD06

P304

Q40578581-44F72F55-AF91-4C14-AC82-C39B3E8103AC

P31

Q40578581-01969C73-F4EA-4E85-B12A-A5A0355C9357

P356

Q40578581-8B4A1ADC-4F76-4946-87FE-82BBBE1C620B

P433

Q40578581-A8E17DAA-094F-4FCB-A64C-208332EDDBFD

P478

Q40578581-D569239F-20BE-4061-8DCF-A532FBF110B8

P50

Q40578581-E05EDAFC-EDD7-43E8-82AC-2A97CAC44F7D

P577

Q40578581-B6752A70-E739-4049-A17F-6E0C5DF9626D

P698

Q40578581-6CF03D8C-4269-404B-9464-F863EDE760C6

P921

Q40578581-EDC49610-2837-40FD-909E-6837799C6DEC

P932

Q40578581-DC98DBEF-E32F-41F0-9C30-8781500B64D8

P356

P1433

Integrative Biology

P1476

Clinically-translated silica n ...... ided surgery and interventions

@en

P2093

Constantinos T Sofocleous

http://www.w3.org/2001/XMLSchema#string

Evan Phillips

http://www.w3.org/2001/XMLSchema#string

Hilda Stambuk

http://www.w3.org/2001/XMLSchema#string

Michelle S Bradbury

http://www.w3.org/2001/XMLSchema#string

Pablo H Montero

http://www.w3.org/2001/XMLSchema#string

Richard J C Meester

http://www.w3.org/2001/XMLSchema#string

Sarah M Cheal

http://www.w3.org/2001/XMLSchema#string

Snehal Patel

http://www.w3.org/2001/XMLSchema#string

Ulrich Wiesner

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Lymphatic imaging in humans with near-infrared fluorescence

Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study.

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.

Use of sentinel node lymphoscintigraphy in malignant melanoma.

Targeting of albumin-embedded paclitaxel nanoparticles to tumors.

Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases.

P304

74-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C2IB20174G

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy C Durack

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23138852

http://www.w3.org/2001/XMLSchema#string

P921

P932

4428677

http://www.w3.org/2001/XMLSchema#string